POLICYMAKERS and health experts are calling for urgent sodium reduction initiatives in the Philippines, including administrative measures, legislation, and industry reformulation, to curb the growing ...

There must be an explanation for the overwhelming rampage of abuse against women and children. When evil men are not beating, ...

Revolution Medicines said its pancreatic cancer drug daraxonrasib succeeded in a Phase 3 trial. RevMed said its drug almost doubled the typical length of survival and slashed the risk of death by 60% ...

Today’s illicit chemists can quickly cook up drugs far more dangerous than fentanyl. By Jonathan Corum and Matt Richtel Illicit labs are creating new synthetic drugs at breakneck speed. Dangerous, ...

CHICAGO (WLS) -- A drug trial at Northwestern Medicine offers hopeful results to those with pancreatic cancer. GI Oncologist Dr. Deva Mahalingam is the lead author for research published on Tuesday.

A designer drug described as 10 times more potent than fentanyl is causing an uptick in U.S. overdoses, according to health officials in multiple states. Known as cychlorphine, the synthetic opioid is ...

GSK GSK-0.82%decrease; red down pointing triangle withdrew its application for a drug touted last year by President Trump as a potential treatment for autism symptoms, just months after the company ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments ...

A glimmer of hope may be on the horizon for a ruthless cancer that former Sen. Ben Sasse (R-Neb.) once called a “definite death sentence.” An experimental treatment from Revolution Medicines helped ...

A psychedelic used in some countries to treat post-traumatic stress disorder is expected to get a closer examination from the federal government on its safety and effectiveness, sources told CBS News.

Finding innovative ways to treat cancer is Pfizer’s biggest priority so to boost cutting-edge technologies, Pfizer executives went to Shenyang, China. There, last summer, Pfizer paid $1.25 billion to ...

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...